This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ryan, E. T. Articles by Calderwood, S. B. Search for Related Content PubMed PubMed Citation Articles by Ryan, E. T. Articles by Calderwood, S. B.

 Previous Article  |  Next Article 

Infect. Immun., 08 1997, 3118-3125, Vol 65, No. 8
Copyright © 1997, American Society for Microbiology

Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice

ET Ryan, JR Butterton, T Zhang, MA Baker, SL Stanley Jr and SB Calderwood
Infectious Disease Unit, Massachusetts General Hospital, Boston 02114, USA.

Entamoeba histolytica is a significant cause of morbidity and mortality worldwide. The serine-rich E. histolytica protein (SREHP) is a surface- expressed trophozoite protein that includes multiple hydrophilic tandem repeats. A purified fusion protein between the dodecapeptide repeat of SREHP and cholera toxin B subunit (CTB) has previously been shown to be immunogenic in mice after oral inoculation when cholera toxin is coadministered as an immunoadjuvant. We engineered a live attenuated El Tor Vibrio cholerae vaccine strain, Peru2, to express the SREHP-12-CTB fusion protein to the supernatant from either a plasmid [Peru2 (pETR5.1)] or from a chromosomal insertion (ETR3). Vector strains were administered orally to germfree mice that were subsequently housed under nongermfree conditions; mice received one (day 0) or two (days 0 and 14) inoculations. No immunoadjuvant or cholera holotoxin was administered. Mice that received two inoculations of Peru2(pETR5.1) had the most pronounced antiamebic systemic and mucosal immunologic responses. Less marked, but significant, anti-SREHP serum immunoglobulin G antibody responses were also induced in mice that received either one or two oral inoculations of strain ETR3. Anti-V. cholerae responses were also induced, as measured by the induction of serum vibriocidal antibodies and by serum and mucosal anti-CTB antibody responses. These results suggest that V. cholerae vector strains can be successful delivery vehicles for the SREHP-12-CTB fusion protein, to induce mucosal and systemic antiamebic and anti-V. cholerae immune responses. The magnitude of these responses is proportional to the amount of SREHP-12-CTB produced by the vector strain.

This article has been cited by other articles:

• Teixeira, J. E., Huston, C. D. (2008). Participation of the Serine-Rich Entamoeba histolytica Protein in Amebic Phagocytosis of Apoptotic Host Cells. Infect. Immun. 76: 959-966 [Abstract] [Full Text]  
• Kotton, C. N., Hohmann, E. L. (2004). Enteric Pathogens as Vaccine Vectors for Foreign Antigen Delivery. Infect. Immun. 72: 5535-5547 [Full Text]  
• Asaduzzaman, M., Ryan, E. T., John, M., Hang, L., Khan, A. I., Faruque, A. S. G., Taylor, R. K., Calderwood, S. B., Qadri, F. (2004). The Major Subunit of the Toxin-Coregulated Pilus TcpA Induces Mucosal and Systemic Immunoglobulin A Immune Responses in Patients with Cholera Caused by Vibrio cholerae O1 and O139. Infect. Immun. 72: 4448-4454 [Abstract] [Full Text]  
• Liang, W., Wang, S., Yu, F., Zhang, L., Qi, G., Liu, Y., Gao, S., Kan, B. (2003). Construction and Evaluation of a Safe, Live, Oral Vibrio cholerae Vaccine Candidate, IEM108. Infect. Immun. 71: 5498-5504 [Abstract] [Full Text]  
• Avall-Jaaskelainen, S., Kyla-Nikkila, K., Kahala, M., Miikkulainen-Lahti, T., Palva, A. (2002). Surface Display of Foreign Epitopes on the Lactobacillus brevis S-Layer. Appl. Environ. Microbiol. 68: 5943-5951 [Abstract] [Full Text]  
• John, M., Crean, T. I., Calderwood, S. B., Ryan, E. T. (2000). In Vitro and In Vivo Analyses of Constitutive and In Vivo-Induced Promoters in Attenuated Vaccine and Vector Strains of Vibrio cholerae. Infect. Immun. 68: 1171-1175 [Abstract] [Full Text]  
• Crean, T. I., John, M., Calderwood, S. B., Ryan, E. T. (2000). Optimizing the Germfree Mouse Model for In Vivo Evaluation of Oral Vibrio cholerae Vaccine and Vector Strains. Infect. Immun. 68: 977-981 [Abstract] [Full Text]  
• Ryan, E. T., Crean, T. I., Kochi, S. K., John, M., Luciano, A. A., Killeen, K. P., Klose, K. E., Calderwood, S. B. (2000). Development of a Delta glnA Balanced Lethal Plasmid System for Expression of Heterologous Antigens by Attenuated Vaccine Vector Strains of Vibrio cholerae. Infect. Immun. 68: 221-226 [Abstract] [Full Text]  
• Ryan, E. T., Crean, T. I., John, M., Butterton, J. R., Clements, J. D., Calderwood, S. B. (1999). In Vivo Expression and Immunoadjuvancy of a Mutant of Heat-Labile Enterotoxin of Escherichia coli in Vaccine and Vector Strains of Vibrio cholerae. Infect. Immun. 67: 1694-1701 [Abstract] [Full Text]